Nucleic Acid Amplification Testing Market Size, Trends & Growth Report By 2033

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Nucleic Acid Amplification Testing Market Size Analysis

Global Nucleic Acid Amplification Testing Market Introduction
By Type
1. Introduction
  1. Type By Value
2. Polymerase Chain Reaction (PCR) Tests
  1. By Value
3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  1. By Value
4. Ligase Chain Reaction (LCR) Tests
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Disease Testing
  1. By Value
  2. COVID-19 Testing
    1. COVID-19 Testing By Value
  3. Mosquito-Borne Disease Testing
    1. Mosquito-Borne Disease Testing By Value
  4. Influenza Testing
    1. Influenza Testing By Value
  5. Sexually Transmitted Infections Testing
    1. Sexually Transmitted Infections Testing By Value
  6. Hepatitis Testing
    1. Hepatitis Testing By Value
  7. Tuberculosis Testing
    1. Tuberculosis Testing By Value
  8. Others
    1. Others By Value
3. Oncology Testing
  1. By Value
4. Genetic Testing
  1. By Value
5. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Diagnostic laboratories
  1. By Value
4. Others
  1. By Value

North America Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Polymerase Chain Reaction (PCR) Tests
  1. By Value
3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  1. By Value
4. Ligase Chain Reaction (LCR) Tests
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Disease Testing
  1. By Value
  2. COVID-19 Testing
    1. COVID-19 Testing By Value
  3. Mosquito-Borne Disease Testing
    1. Mosquito-Borne Disease Testing By Value
  4. Influenza Testing
    1. Influenza Testing By Value
  5. Sexually Transmitted Infections Testing
    1. Sexually Transmitted Infections Testing By Value
  6. Hepatitis Testing
    1. Hepatitis Testing By Value
  7. Tuberculosis Testing
    1. Tuberculosis Testing By Value
  8. Others
    1. Others By Value
3. Oncology Testing
  1. By Value
4. Genetic Testing
  1. By Value
5. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Diagnostic laboratories
  1. By Value
4. Others
  1. By Value
U.S.
1. By Type
  1. Introduction
    1. Type By Value
  2. Polymerase Chain Reaction (PCR) Tests
    1. By Value
  3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    1. By Value
  4. Ligase Chain Reaction (LCR) Tests
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Disease Testing
    1. By Value
    2. COVID-19 Testing
      1. COVID-19 Testing By Value
    3. Mosquito-Borne Disease Testing
      1. Mosquito-Borne Disease Testing By Value
    4. Influenza Testing
      1. Influenza Testing By Value
    5. Sexually Transmitted Infections Testing
      1. Sexually Transmitted Infections Testing By Value
    6. Hepatitis Testing
      1. Hepatitis Testing By Value
    7. Tuberculosis Testing
      1. Tuberculosis Testing By Value
    8. Others
      1. Others By Value
  3. Oncology Testing
    1. By Value
  4. Genetic Testing
    1. By Value
  5. Others
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Diagnostic laboratories
    1. By Value
  4. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Polymerase Chain Reaction (PCR) Tests
  1. By Value
3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  1. By Value
4. Ligase Chain Reaction (LCR) Tests
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Disease Testing
  1. By Value
  2. COVID-19 Testing
    1. COVID-19 Testing By Value
  3. Mosquito-Borne Disease Testing
    1. Mosquito-Borne Disease Testing By Value
  4. Influenza Testing
    1. Influenza Testing By Value
  5. Sexually Transmitted Infections Testing
    1. Sexually Transmitted Infections Testing By Value
  6. Hepatitis Testing
    1. Hepatitis Testing By Value
  7. Tuberculosis Testing
    1. Tuberculosis Testing By Value
  8. Others
    1. Others By Value
3. Oncology Testing
  1. By Value
4. Genetic Testing
  1. By Value
5. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Diagnostic laboratories
  1. By Value
4. Others
  1. By Value
U.K.
1. By Type
  1. Introduction
    1. Type By Value
  2. Polymerase Chain Reaction (PCR) Tests
    1. By Value
  3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    1. By Value
  4. Ligase Chain Reaction (LCR) Tests
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Disease Testing
    1. By Value
    2. COVID-19 Testing
      1. COVID-19 Testing By Value
    3. Mosquito-Borne Disease Testing
      1. Mosquito-Borne Disease Testing By Value
    4. Influenza Testing
      1. Influenza Testing By Value
    5. Sexually Transmitted Infections Testing
      1. Sexually Transmitted Infections Testing By Value
    6. Hepatitis Testing
      1. Hepatitis Testing By Value
    7. Tuberculosis Testing
      1. Tuberculosis Testing By Value
    8. Others
      1. Others By Value
  3. Oncology Testing
    1. By Value
  4. Genetic Testing
    1. By Value
  5. Others
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Diagnostic laboratories
    1. By Value
  4. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Polymerase Chain Reaction (PCR) Tests
  1. By Value
3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  1. By Value
4. Ligase Chain Reaction (LCR) Tests
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Disease Testing
  1. By Value
  2. COVID-19 Testing
    1. COVID-19 Testing By Value
  3. Mosquito-Borne Disease Testing
    1. Mosquito-Borne Disease Testing By Value
  4. Influenza Testing
    1. Influenza Testing By Value
  5. Sexually Transmitted Infections Testing
    1. Sexually Transmitted Infections Testing By Value
  6. Hepatitis Testing
    1. Hepatitis Testing By Value
  7. Tuberculosis Testing
    1. Tuberculosis Testing By Value
  8. Others
    1. Others By Value
3. Oncology Testing
  1. By Value
4. Genetic Testing
  1. By Value
5. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Diagnostic laboratories
  1. By Value
4. Others
  1. By Value
China
1. By Type
  1. Introduction
    1. Type By Value
  2. Polymerase Chain Reaction (PCR) Tests
    1. By Value
  3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    1. By Value
  4. Ligase Chain Reaction (LCR) Tests
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Disease Testing
    1. By Value
    2. COVID-19 Testing
      1. COVID-19 Testing By Value
    3. Mosquito-Borne Disease Testing
      1. Mosquito-Borne Disease Testing By Value
    4. Influenza Testing
      1. Influenza Testing By Value
    5. Sexually Transmitted Infections Testing
      1. Sexually Transmitted Infections Testing By Value
    6. Hepatitis Testing
      1. Hepatitis Testing By Value
    7. Tuberculosis Testing
      1. Tuberculosis Testing By Value
    8. Others
      1. Others By Value
  3. Oncology Testing
    1. By Value
  4. Genetic Testing
    1. By Value
  5. Others
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Diagnostic laboratories
    1. By Value
  4. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Polymerase Chain Reaction (PCR) Tests
  1. By Value
3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  1. By Value
4. Ligase Chain Reaction (LCR) Tests
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Disease Testing
  1. By Value
  2. COVID-19 Testing
    1. COVID-19 Testing By Value
  3. Mosquito-Borne Disease Testing
    1. Mosquito-Borne Disease Testing By Value
  4. Influenza Testing
    1. Influenza Testing By Value
  5. Sexually Transmitted Infections Testing
    1. Sexually Transmitted Infections Testing By Value
  6. Hepatitis Testing
    1. Hepatitis Testing By Value
  7. Tuberculosis Testing
    1. Tuberculosis Testing By Value
  8. Others
    1. Others By Value
3. Oncology Testing
  1. By Value
4. Genetic Testing
  1. By Value
5. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Diagnostic laboratories
  1. By Value
4. Others
  1. By Value
UAE
1. By Type
  1. Introduction
    1. Type By Value
  2. Polymerase Chain Reaction (PCR) Tests
    1. By Value
  3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    1. By Value
  4. Ligase Chain Reaction (LCR) Tests
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Disease Testing
    1. By Value
    2. COVID-19 Testing
      1. COVID-19 Testing By Value
    3. Mosquito-Borne Disease Testing
      1. Mosquito-Borne Disease Testing By Value
    4. Influenza Testing
      1. Influenza Testing By Value
    5. Sexually Transmitted Infections Testing
      1. Sexually Transmitted Infections Testing By Value
    6. Hepatitis Testing
      1. Hepatitis Testing By Value
    7. Tuberculosis Testing
      1. Tuberculosis Testing By Value
    8. Others
      1. Others By Value
  3. Oncology Testing
    1. By Value
  4. Genetic Testing
    1. By Value
  5. Others
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Diagnostic laboratories
    1. By Value
  4. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Type
1. Introduction
  1. Type By Value
2. Polymerase Chain Reaction (PCR) Tests
  1. By Value
3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
  1. By Value
4. Ligase Chain Reaction (LCR) Tests
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Infectious Disease Testing
  1. By Value
  2. COVID-19 Testing
    1. COVID-19 Testing By Value
  3. Mosquito-Borne Disease Testing
    1. Mosquito-Borne Disease Testing By Value
  4. Influenza Testing
    1. Influenza Testing By Value
  5. Sexually Transmitted Infections Testing
    1. Sexually Transmitted Infections Testing By Value
  6. Hepatitis Testing
    1. Hepatitis Testing By Value
  7. Tuberculosis Testing
    1. Tuberculosis Testing By Value
  8. Others
    1. Others By Value
3. Oncology Testing
  1. By Value
4. Genetic Testing
  1. By Value
5. Others
  1. By Value
By End-User
1. Introduction
  1. End-User By Value
2. Hospitals
  1. By Value
3. Diagnostic laboratories
  1. By Value
4. Others
  1. By Value
Brazil
1. By Type
  1. Introduction
    1. Type By Value
  2. Polymerase Chain Reaction (PCR) Tests
    1. By Value
  3. Isothermal Nucleic Acid Amplification Technology (INAAT) Tests
    1. By Value
  4. Ligase Chain Reaction (LCR) Tests
    1. By Value
2. By Application
  1. Introduction
    1. Application By Value
  2. Infectious Disease Testing
    1. By Value
    2. COVID-19 Testing
      1. COVID-19 Testing By Value
    3. Mosquito-Borne Disease Testing
      1. Mosquito-Borne Disease Testing By Value
    4. Influenza Testing
      1. Influenza Testing By Value
    5. Sexually Transmitted Infections Testing
      1. Sexually Transmitted Infections Testing By Value
    6. Hepatitis Testing
      1. Hepatitis Testing By Value
    7. Tuberculosis Testing
      1. Tuberculosis Testing By Value
    8. Others
      1. Others By Value
  3. Oncology Testing
    1. By Value
  4. Genetic Testing
    1. By Value
  5. Others
    1. By Value
3. By End-User
  1. Introduction
    1. End-User By Value
  2. Hospitals
    1. By Value
  3. Diagnostic laboratories
    1. By Value
  4. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Nucleic Acid Amplification Testing Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

F. Hoffmann-La Roche Ltd
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Becton, Dickinson, and Company
Danaher Corporation
Abbott Laboratories
Illumina, Inc.
Siemens Healthineers
bioMérieux SA
Novartis AG
Bio-Rad Laboratories, Inc.
Seegene Inc.
Agilent Technologies
BioMérieux
GenMark Diagnostics
Visby Medical

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment